Value of proprotein convertase subtilisin/kexin type 9 and inflammatory markers in the diagnosis of carotid atherosclerosis in hypertensive men

QR Code

Value of proprotein convertase subtilisin/kexin type 9 and inflammatory markers in the diagnosis of carotid atherosclerosis in hypertensive men

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in lipid metabolism, has local and systemic effects in immunoregulation and atherogenesis in hypertensive patients.Aim. To personalize cardiovascular risk (CVR) stratification taking into account the diagnostic value of PCSK9 and infl...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. Yu. Vukolova, E. Yu. Gubareva, I. V. Gubareva, O. A. Germanova, G. I. Kiseleva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-10-01
Series:	Российский кардиологический журнал
Subjects:	pcsk9 hypertension interleukins -8, -10 carotid atherosclerosis
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5939
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Relationship of sortilin and proprotein convertase subtilisin/kexin type 9 in blood serum with the severity of carotid and coronary atherosclerosis in hypertensive patients
by: Yu. Yu. Vukolova, et al.
Published: (2022-06-01)

THE ROLE OF THE PROPROTEIN CONVERTASE SUBTILISIN / KEXIN TYPE 9 (PCSK9) IN THE PATHOPHYSIOLOGY OF ATHEROSCLEROSIS
by: Алексей Михайлович Чаулин, et al.
Published: (2019-12-01)

Levels of proprotein convertase subtilisin/kexin type 9 in patients with acute myocardial infarction
by: A. D. Gimadeeva, et al.
Published: (2020-03-01)

Subtilisin/kexin type 9 protein convertase and interleukin 1 beta alterations in acute myocardial infarction
by: Michał Majewski, et al.
Published: (2025-05-01)

ASSOTIATION OF THE GENETIC POLYMORPHISM E670G OF THE PCSK-9 AND THE SEVERITY OF THE CAROTID ATHEROSCLEROSIS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN UZBEK POPULATION
by: R. B. Alieva, et al.
Published: (2019-09-01)

Cholesteryl Ester Species but Not Serum Proprotein Convertase Subtilisin/Kexin Type 9 Levels Decline in Male Patients with Active Inflammatory Bowel Disease
by: Angelika Hettenbach, et al.
Published: (2025-03-01)

Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis
by: A. Yu. Filatova, et al.
Published: (2019-06-01)

Atherosclerosis and inflammation – the path from pathogenesis to treatment: review of the current state of the issue (part 2)
by: A. A. Avagimyan, et al.
Published: (2025-07-01)

Observational study of inclisiran effectiveness in Moscow healthcare
by: A. I. Sapina, et al.
Published: (2023-12-01)

Effectiveness of inclisiran lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Moscow healthcare
by: A. I. Sapina, et al.
Published: (2024-06-01)

СОХРАНЕНИЕ РЕЦЕПТОРОВ ЛПНП — НОВЫЙ ПОДХОД К ТЕРАПИИ ГИПЕРЛИПИДЕМИИ
by: С. С. Бажан
Published: (2013-12-01)

Analysis of The Use of PCSK9 Inhibitors in Clinical Practice
by: S. Yu. Volkova, et al.
Published: (2023-03-01)

Comparative effectiveness of different methods of prescribing rosuvastatin and ezetimibe in combination with PCSK9 inhibitors
by: A. A. Kuznetsov, et al.
Published: (2024-06-01)

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)

Lipid Profile, PCSK9, ANGPTL3 and Lipoprotein (a) Levels in Men Diagnosed With Localized High‐Grade Prostate Cancer and Men At‐Risk of Prostate Cancer
by: Ann‐Charlotte Bergeron, et al.
Published: (2025-02-01)

ENDOVASCULAR TREATMENT OF CAROTID ATHEROSCLEROSIS: CONCERNS AND PERSPECTIVES
by: T. V. Tvorogova, et al.
Published: (2017-03-01)

PCSK9 inhibitors for in-hospital treatment of patients with acute coronary syndrome and severe lipid metabolism disorders
by: O. L. Barbarash, et al.
Published: (2020-09-01)

PREDICTORS OF HYPOXIC ISCHEMIC ENCEPHALOPATHY IN NEWBORNS
by: V. A. Sergeeva, et al.
Published: (2018-01-01)

New opportunities for lowering low-density lipoprotein cholesterol: comparative characteristics of PCSK9-targeted therapy
by: S. K. Zyryanov, et al.
Published: (2022-12-01)

Atherosclerosis of the carotid arteries: clinical significance (a literature review)
by: M. A. Fedorina, et al.
Published: (2023-07-01)

Novel method for glomus-saving carotid endarterectomy sensu A. N. Kazantsev: cutting the internal carotid artery on the site from external and common carotid artery
by: A. N. Kazantsev, et al.
Published: (2020-09-01)

Carotid artery elasticity in young men with arterial hypertension
by: V. R. Yurtaeva, et al.
Published: (2009-08-01)

Vasoprotective statin effectiveness in patients with carotid atherosclerosis
by: Yu. B. Belousov, et al.
Published: (2007-10-01)

HIGH INTENSITY HYPOLIPIDEMIC THERAPY AND DECREASED LEVEL OF LOW DENSITY LIPOPROTEIDES CHOLESTEROL: IS THE APPROACH JUSTIFIED? POINT OF VIEW
by: M. G. Bubnova
Published: (2018-07-01)

PCSK9 inhibitors reduces arterial stiffness in patients with acute coronary syndrome
by: Wang Liang, et al.
Published: (2025-01-01)

Carotid Endarterectomy and Stenting of the Internal Carotid Artery in Patients with Occlusion of the Contralateral Carotid Artery
by: N. S. Gorshkov, et al.
Published: (2025-01-01)

Carotid Atherosclerosis Severity in Unorganized Adult Population
by: V. S. Kaveshnikov, et al.
Published: (2019-03-01)

Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors
by: D. Yu. Sedykh, et al.
Published: (2022-07-01)

Effect of combined lipid-lowering therapy on atherosclerotic plaque vulnerability in patients with acute coronary syndrome (Combi-LLT ACS): randomized trial protocol
by: A. N. Kovalskaya, et al.
Published: (2022-12-01)

Statin Intolerance and Adverse Effects in Lipid-Lowering Therapy – Pathomechanisms, Management Strategies, and Alternative Treatment Approaches
by: Natalia Śliwa, et al.
Published: (2025-06-01)

PROGRESSION OF CAROTID ARTERY ATHEROSCLEROSIS DURING TREATMENT TO TARGET IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
by: E. V. Udachkina, et al.
Published: (2018-09-01)

OPERATIONS ON THE CAROTID ARTERIES FOR ACUTE PERIOD OF ISCHEMIC STROKE
by: Mikhail S. Mikhailov, et al.
Published: (2017-09-01)

Dynamics of resistant hypertension in the postoperative period of carotid endarterectomy with and without carotid body saving
by: A. N. Kazantsev, et al.
Published: (2021-05-01)

Methods of carotid endarterectomy
by: A. N. Kazantsev, et al.
Published: (2021-10-01)

Lipid-lowering treatment in the improvement of outcomes in patients with atherosclerotic cardiovascular disease and diabetes mellitus: the role of PCSK9 inhibitors
by: G. R. Galstyan, et al.
Published: (2018-12-01)

Emergency Glomus-Sparing Carotid Endarterectomy According to A.N. Kazantsev
by: A. N. Kazantsev, et al.
Published: (2021-01-01)

Successful Surgical Management of a Coincidence of Three‐Vessel Coronary Artery Disease, Severe Carotid Atherosclerosis, and Carotid Paraganglioma: A Case Report and Literature Review
by: Pouya Ebrahimi, et al.
Published: (2025-07-01)

CarotidSCORE.RU — risk stratification for complications after carotid endarterectomy
by: A. N. Kazantsev, et al.
Published: (2022-06-01)

THE INFLUENCE OF HYPOLIPIDEMIC THERAPY ON THE LEVEL OF MODIFIED LOW DENSITY LIPOPROTEIDES
by: V. Z. Lankin, et al.
Published: (2018-09-01)

Does vitamin D supplementation benefit, harm, or have no effects on pregnant women or their babies?
by: article Editorial
Published: (2024-10-01)